Division of Urology, Department of Surgery, Warren Alpert Medical School of Brown University and the Miriam and Rhode Island Hospitals, Providence, Rhode Island.
Fertil Steril. 2018 Jun;109(6):944-945. doi: 10.1016/j.fertnstert.2018.04.027.
Personalized medicine and precision medicine are presenting new opportunities for better patient care, but also present unique challenges. The traditional randomized clinical trial is not necessarily the most appropriate approach to evaluating what may be the best treatment for an individual. Alternative study designs pose unique regulatory challenges for the U.S. Food and Drug Administration but offer the opportunity for higher response rates. Ovarian stimulation for assisted reproductive technology offers opportunities for personalized and more precise approaches to individual patient care.
个体化医学和精准医学为更好的患者护理带来了新的机遇,但也带来了独特的挑战。传统的随机临床试验不一定是评估什么可能是个体最佳治疗方法的最合适方法。替代研究设计对美国食品和药物管理局提出了独特的监管挑战,但也为更高的响应率提供了机会。辅助生殖技术中的卵巢刺激为个体化和更精确的患者护理方法提供了机会。